ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV, trading under the ticker ARYD, is a blank-check company that completed its initial public offering in March 2021 via a 424B4 prospectus filed with the SEC. Sponsored by ARYA Sciences Holdings IV, an affiliate of healthcare-focused investment firm Perceptive Advisors, ARYD was formed to identify and execute a business combination with a target in the life sciences and biotechnology sector. The ARYA series represents one of the more prolific SPAC sponsor franchises in the healthcare space, having launched multiple vehicles across consecutive years. For full filing details, deal status, and comparable life sciences SPAC data, sign up for access at SpacDesk.